Bone Growth Stimulator Global Market Report 2024 Market Size, Trends And Forecast Report 2024-2033

The bone growth stimulator market size has grown rapidly in recent years. It will grow from $1.53 billion in 2023 to $1.69 billion in 2024 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to aging population and orthopedic conditions, increasing awareness of non-invasive treatments, expansion of healthcare access, favorable reimbursement policies, increased demand for minimally invasive solutions , and increased orthopedic surgery prevalence.

The bone growth stimulator market size is expected to see strong growth in the next few years. It will grow to $2.45 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to enhanced public awareness, regenerative medicine adoption, healthcare infrastructure investments, expanding applications and indications, and supportive healthcare policies. Major trends in the forecast period include regenerative medicine, the use of 3d printing technology, incorporating wireless and iot technologies for remote patient monitoring, patient-centric care, and increasing utilization of telemedicine.

Market Overview -
The bone growth stimulator is an electrical osteogenesis stimulator used to boost the natural fusion of bone after a fracture. The purpose of BGS is to send more energy to the healing bone surface through either pulsed electromagnetic or ultrasound. The electromagnetic field allows attracting the two oppositely charged ends of the bones to each other by stimulating new bone growth and fusion, which leads to healing. The bone growth stimulator is used to boost bone healing for difficult to heal fractures or fusions through applying ultrasonic or electrical current to the fracture/fusion site.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=6885&type=smp

Fueling Market Expansion The Role Of Increasing Bone Fractures In The Growth Of The Bone Growth Stimulators Market
The rising number of bone fractures is expected to significantly drive the growth of the bone growth stimulators market. A person's bones typically weaken with age, dietary habitat, and other chronic disorders. The overuse or repetitive motions can tire muscles and put more pressure on the bones, leading to bone fracture. For instance, Amgen, a US-based biotechnology company, presented numbers in May 2022 stating that osteoporosis causes around 1.5 million fractures annually in the United States, resulting in $19 billion in associated expenses. In addition, it is predicted that from 2018 to 2040, there would be a 68% increase in the number of osteoporotic fractures every year, from 1.9 million to 3.2 million. Therefore, the rise in the number of bone fractures is expected to drive the growth of the bone growth stimulator market.

Competitive Landscape -
Major companies operating in the bone growth stimulator market include Arthrex Inc., DJO Global Inc., Stryker Corporation, Bioventus LLC, Zimmer Biomet Holdings Inc., 3M Company, Ambu A/S, Becton Dickinson and Company, Cognionics Inc., ConMed Corporation, The Cooper Companies Inc., DyMedix Corporation, Koninklijke Philips N.V., Medtronic plc, Natus Medical Incorporated, Terumo Corporation, Orthofix Medical Inc., Ossatec Benelux BV, BTT Health GmbH, Stimulate Health Inc., ZimVie Inc., Enovis Inc., DePuy Synthes Inc., Smith & Nephew plc, BioTek Instruments Inc., BioMimetic Therapeutics Inc., Cerament, Cook Medical LLC, Curasan AG, Exactech Inc., Globus Medical Inc., Integra LifeSciences Corporation, Medartis AG, NuVasive Inc., OrthoPediatrics Corp., RTI Surgical Holdings Inc., Wright Medical Group N.V.

Revolutionizing Healing With Technology Advancements In The Bone Growth Stimulators Market, Featuring Orthofix Medical's Accelstim
Technological advancement is a key trend gaining popularity in the bone growth stimulators market. Electrical Bone Growth Stimulation (EBGS) is a unique approach to accelerate healing and promote fusion success rates. Increased experience and widespread EBGS devices have led to significant advancements in stimulation paradigms and clinical outcomes. For instance, in May 2022, Orthofix Medical Inc., a US-based Spinal, orthopedic, bone development solution manufacturer declared that the U.S. Food and Drug Administration (FDA) granted pre-market approval for the AccelStim bone healing therapy Class III device. The AccelStim device is a nonsurgical therapy option for approved new fractures as well as fractures that are still healing (nonunions). To enhance fracture healing, the gadget delivers a Low-Intensity Pulsed Ultrasound (LIPUS) signal to assist the bone's natural healing process.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/bone-growth-stimulator-global-market-report

Key Segments -

The bone growth stimulator market covered in this report is segmented -

1) By Type: Bone Growth Stimulation Devices, Bone Morphogenetic Proteins (BMP), Platelet-Rich Plasma (PRP) Therapy
2) By Type Of Use: Implantable Device, External Device
3) By Application: Fractures, Spinal Fusion, Osteogenesis, Arthrodesis Treatment, Spondylolithesis
4) By End User: Hospitals & ASCs, Speciality Clinics, Home Care

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

"Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

"Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.